[DEPARTMENT PERSONNEL ORDER NO. 2022- 1245] Appointment of the New Member of the Health Technology Assessment Council Subcommittee on Drugs
preliminary recommendation for the inclusion of Potassium Citrate 1620 mg (15 mEq) tablet in the PNF.
[DEPARTMENT PERSONNEL ORDER NO. 2022- 1102] Authority for Select Department of Health (DOH) Personnel to conduct a Hybrid Workshop on the Development of Guidelines in the Creation of the Philippine Essential Medical Device List (PEMDL) on April 22, 2022 in Metro Manila,
[DEPARTMENT CIRCULAR NO. 2022- 0164] Health Technology Assessment Council (HTAC) Recommendation for reinclusion of vasopressin 20 iU/ml (IM/IV) in the Philippine National Formulary
preliminary recommendation for the inclusion of rituximab 1400 mg/ 11.7 mL solution for subcutaneous (SC) injection for the treatment of non-Hodgkin’s lymphoma
[DEPARTMENT CIRCULAR NO. 2022- 0074] Nomination to the Health Technology Assessment Council (HTAC) Subcommittee on Drugs
[DEPARTMENT CIRCULAR NO. 2022- 0015] Health Technology Assessment Council (HTAC) Recommendation to include Sambong 250mg Tablet in the Philippine national Formulary
preliminary recommendation for the non-inclusion of pertuzumab for human epidermal growth factor receptor 2 (HER2)-positive breast cancer
